22157.jpg
Global Psoriatic Arthritis Drug Forecast and Market Analysis to 2028: Oral Therapeutics Dominate the Late-Stage PsA Pipeline
09 nov. 2020 07h48 HE | Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. Current therapies...
22157.jpg
$12.6 Billion Crohn's Disease Market - Global Drug Forecast and Market Analysis 2020-2029
23 oct. 2020 04h23 HE | Research and Markets
Dublin, Oct. 23, 2020 (GLOBE NEWSWIRE) -- The "Crohn's Disease - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. Global sales in the...
22157.jpg
Rheumatoid Arthritis in 7 Major Markets 2017-2030: United States, Germany, France, Italy, Spain, United Kingdom and Japan
02 sept. 2020 05h24 HE | Research and Markets
Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. ...
ARC logo.png
Tumor Necrosis Factor Inhibitor Drugs Market Size Worth US$ 41 Bn by 2026
19 juil. 2019 10h00 HE | Acumen Research and Consulting
LOS ANGELES, July 19, 2019 (GLOBE NEWSWIRE) -- The global TNF inhibitor drugs market is estimated to grow at CAGR above 0.6% over the forecast time frame 2019 to 2026 and reach the market value...